SCHEMBL7120580

SCHEMBL7120580

CC(C)(C)c1ccc([S+](c2ccc(C(C)(C)C)cc2)c2ccc(C(C)(C)C)cc2)cc1.COc1cc(S(=O)(=O)[O-])ccc1OS(=O)(=O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.49
HSD17B3 P37058 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
ALDH1A1 P00352 12/20 0.43
MAPT P10636 9/20 0.43
HTT P42858 5/20 0.43
GAA P10253 4/20 0.43
EYA2 O00167 1/20 0.43
KMT2A Q03164 6/20 0.42
MEN1 O00255 5/20 0.42
TDP1 Q9NUW8 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
PKM P14618 2/20 0.42
LMNA P02545 5/20 0.41
PTPN1 P18031 1/20 0.40
HPGD P15428 2/20 0.39
POLB P06746 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7113148 0.94 ALDH1A1 (0.46) HSD11B1HSD17B3SMN1; SMN2NPC1RAB9A
SCHEMBL7119951 0.91 GFER (0.48) HSD11B1HSD17B3SMN1; SMN2ALDH1A1MAPT
SCHEMBL7119930 0.84 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL7112620 0.83 ALDH1A1 (0.53) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL6741516 0.83 HSD11B1 (0.50) HSD11B1HSD17B3SMN1; SMN2NPC1RAB9A
SCHEMBL7118517 0.82 GFER (0.55) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL7120586 0.81 HSD11B1 (0.51) HSD11B1HSD17B3SMN1; SMN2NPC1RAB9A
SCHEMBL7112619 0.81 ALDH1A1 (0.45) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL6744469 0.81 TDP1 (0.49) HSD11B1HSD17B3SMN1; SMN2ALDH1A1MAPT
SCHEMBL6745171 0.80 HSD11B1 (0.52) HSD11B1HSD17B3NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6551758-B2 For use in microfabrication of integrated circuits SHIN-ETSU CHEMICAL CO. LTD. (JP) 2003-04-22 US disclosed
US-20020077493-A1 Novel onium salts, photoacid generators, resist compositions, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020077493-A1 Novel onium salts, photoacid generators, resist compositions, and patterning process ABL1, PI4K2B, FES HSD11B1 3053/4885HSD17B3 3532/4885SMN1; SMN2 2822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.